Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)

v3.21.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2019 185 52 135,990,491      
Beginning Balance, Amount at Dec. 31, 2019 $ 1,340,566 $ 362,059 $ 135,990 $ 127,708,773 $ (125,105,539) $ 4,441,849
Shares issued directors, shares 320,844      
Shares issued to directors, value $ 321 17,679 18,000
Stock-based compensation expense related to employee stock options 1,815 1,815
Net loss attributable to common stockholders (652,501) (652,501)
Ending Balance, Shares at Mar. 31, 2020 185 52 136,311,335      
Ending Balance, Amount at Mar. 31, 2020 $ 1,340,566 $ 362,059 $ 136,311 127,728,267 (125,758,040) 3,809,163
Beginning Balance, Shares at Dec. 31, 2020 185 52 136,311,335      
Beginning Balance, Amount at Dec. 31, 2020 $ 1,340,566 $ 362,059 $ 136,311 127,733,714 (128,255,391) 1,317,259
Shares issued directors, shares      
Shares issued to directors, value
Stock-based compensation expense related to employee stock options 1,815 1,815
Net loss attributable to common stockholders 82,739 82,739
Ending Balance, Shares at Mar. 31, 2021 185 52 136,311,335      
Ending Balance, Amount at Mar. 31, 2021 $ 1,340,566 $ 362,059 $ 136,311 $ 127,735,529 $ (128,172,652) $ 1,401,813